Clinical Trial Update: NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating nanoliposomal irinotecan with fluorouracil and leucovorin in advanced biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• Nanoliposomal irinotecan (irinotecan liposomal)

Snippet

Sponsor: Georgetown University | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING